Skip to main content
Log in

Metabolic inflammatory volume and total inflammatory glycolysis: novel parameters to evaluate PET-CT disease activity in Takayasu arteritis

  • BRIEF REPORT
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate diagnostic accuracy for active Takayasu arteritis (TAK) for two novel 18F-fluorodeoxyglucose PET-CT parameters, the inflammatory volume (MIV) and total inflammatory glycolysis (TIG), to quantitate volume of metabolically-active arterial tissue.

Methods

From a cohort of TAK (n = 36, 35 immunosuppressive-naïve), images of PET-CTs were reviewed for mean and maximum standardized uptake value (SUVmean and SUVmax), target-to-blood pool ratio (TBR), target-to-liver ratio (TLR), and PET Vasculitis Activity Score (PETVAS). Regions of interest were drawn to semiautomatically calculate MIV in areas of 18F-fluorodeoxyglucose uptake ≥ 1.5 SUVmean after excluding physiological tracer uptake. TIG was calculated by multiplying MIV with SUVmean. PET-CT parameters, ESR, CRP, and clinical disease activity scores were compared against the gold standard of physician global assessment of disease activity (PGA, active/inactive).

Results

Using dichotomized cut-offs for active TAK at SUVmax (≥ 2.21), SUVmean (≥ 1.58), TBR (≥ 2.31), TLR (≥ 1.22), PETVAS (various cut-offs), ESR (≥ 40 mm/hour), and CRP (≥ 6 mg/L), the novel indices MIV (≥ 1.8) and TIG (≥ 2.7) performed similar [area under the receiver operating characteristics curve (AUC) 0.873 for both] to SUVmax (AUC 0.841) and SUVmean (AUC 0.851), and better than TBR (AUC 0.773), TLR (AUC 0.773), PETVAS [≥ 5.5 (AUC 0.750), ≥ 10 (AUC 0.636), ≥ 15 (AUC 0.546)], ESR (AUC 0.748), or CRP (AUC 0.731). MIV and TIG had similar agreement with PGA or CRP as with SUVmax or SUVmean, and better agreement than TBR, TLR, or PETVAS cut-offs.

Conclusions

MIV and TIG performed similarly, therefore, are viable alternatives to existing PET-CT parameters to assess TAK disease activity in this preliminary report.

Key Points

• MIV and TIG performed similar to SUVmax and SUVmax for disease activity assessment in TAK.

• MIV and TIG distinguished active TAK better than TBR, TLR, PETVAS cut-offs, ESR, or CRP.

• MIV and TIG had better agreement with PGA or CRP than TBR, TLR, or PETVAS cut-offs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

All the analyses performed for this article have been reported in the main text or in the supplementary files. Data pertaining to the article shall be shared on reasonable request to the corresponding author (Durga Prasanna Misra, durgapmisra@gmail.com).

References

  1. Misra DP, Wakhlu A, Agarwal V, Danda D (2019) Recent advances in the management of Takayasu arteritis. Int J Rheum Dis 22(Suppl 1):60–68. https://doi.org/10.1111/1756-185x.13285

    Article  CAS  PubMed  Google Scholar 

  2. Misra DP, Jain N, Ora M, Singh K, Agarwal V, Sharma A (2022) Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis. Diagnostics (Basel) 12(10):2565. https://doi.org/10.3390/diagnostics12102565

    Article  CAS  PubMed  Google Scholar 

  3. Galli E, Muratore F, Mancuso P, Boiardi L, Marvisi C, Besutti G, Spaggiari L, Casali M, Versari A, Giorgi Rossi P, Salvarani C (2022) The role of PET/CT in disease activity assessment in patients with large vessel vasculitis. Rheumatology (Oxford) 61(12):4809–4816. https://doi.org/10.1093/rheumatology/keac125

    Article  CAS  PubMed  Google Scholar 

  4. Incerti E, Tombetti E, Fallanca F, Baldissera EM, Alongi P, Tombolini E, Sartorelli S, Sabbadini MG, Papa M, De Cobelli F, Mason JC, Gianolli L, Manfredi AA, Picchio M (2017) 18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis. Eur J Nucl Med Mol Imaging 44(7):1109–1118. https://doi.org/10.1007/s00259-017-3639-y

    Article  CAS  PubMed  Google Scholar 

  5. Quinn KA, Alessi HD, Ponte C, Rose E, Ahlman MA, Redmond C, Luo Y, Bolek EC, Langford CA, Merkel PA, Grayson PC (2022) Use of 18F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu’s arteritis. Rheumatology (Oxford) 61(10):4047–4055. https://doi.org/10.1093/rheumatology/keac021

    Article  CAS  PubMed  Google Scholar 

  6. Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, Cupps TR, Kaplan MJ, Malayeri AA, Merkel PA, Novakovich E, Bluemke DA, Ahlman MA (2018) F-18-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis. Arthritis Rheumatol 70(3):439–449. https://doi.org/10.1002/art.40379

    Article  PubMed  PubMed Central  Google Scholar 

  7. Dashora HR, Rosenblum JS, Quinn KA, Alessi H, Novakovich E, Saboury B, Ahlman MA, Grayson PC (2022) Comparing Semiquantitative and Qualitative Methods of Vascular (18)F-FDG PET Activity Measurement in Large-Vessel Vasculitis. J Nucl Med 63(2):280–286. https://doi.org/10.2967/jnumed.121.262326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lim R, Eaton A, Lee NY, Setton J, Ohri N, Rao S, Wong R, Fury M, Schöder H (2012) 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. J Nucl Med 53(10):1506–1513. https://doi.org/10.2967/jnumed.111.101402

    Article  CAS  PubMed  Google Scholar 

  9. Arshad MA, Gitau S, Tam H, Park WE, Patel NH, Rockall A, Aboagye EO, Bharwani N, Barwick TD (2021) Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography. Eur J Nucl Med Mol Imaging 48(6):2009–2023. https://doi.org/10.1007/s00259-020-05136-8

    Article  CAS  PubMed  Google Scholar 

  10. Misra DP, Tomelleri A, Rathore U, Benanti G, Singh K, Behera MR, Jain N, Ora M, Bhadauria DS, Gambhir S, Kumar S, Baldissera E, Agarwal V, Campochiaro C, Dagna L (2022) Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India. Diagnostics (Basel) 12(12):3102. https://doi.org/10.3390/diagnostics12123102

    Article  CAS  PubMed  Google Scholar 

  11. Misra DP, Rathore U, Mishra P, Singh K, Thakare DR, Behera MR, Jain N, Ora M, Bhadauria DS, Gambhir S, Kumar S, Agarwal V (2022) Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack-A Retrospective Cohort Study. Life (Basel) 12(11):1904. https://doi.org/10.3390/life12111904

    Article  CAS  PubMed  Google Scholar 

  12. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134

    Article  CAS  PubMed  Google Scholar 

  13. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11. https://doi.org/10.1002/art.37715

    Article  CAS  PubMed  Google Scholar 

  14. Zhang X, Zhou J, Sun Y, Shi H, Ji Z, Jiang L (2018) (18)F-FDG-PET/CT: an accurate method to assess the activity of Takayasu’s arteritis. Clin Rheumatol 37(7):1927–1935. https://doi.org/10.1007/s10067-017-3960-7

    Article  PubMed  Google Scholar 

  15. Tahra SK, Özgüven S, Ünal AU, Öner FA, Öneş T, Erdil TY, Direskeneli H (2022) Assessment of Takayasu arteritis in routine practice with PETVAS, an 18F-FDG PET quantitative scoring tool. Turk J Med Sci 52(2):313–322. https://doi.org/10.55730/1300-0144.5317

    Article  PubMed  Google Scholar 

  16. Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA (2017) A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis. Arthritis Rheumatol 69(4):846–853. https://doi.org/10.1002/art.40037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pugh D, Dhaun N (2022) Comment on: A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG PET/CT: a Chinese cohort study. Rheumatology (Oxford) 61(Si):Si97-si98. https://doi.org/10.1093/rheumatology/keab802

    Article  CAS  PubMed  Google Scholar 

  18. Campochiaro C, Misra DP (2022) PET in Takayasu arteritis: onwards and upwards towards a future of robust multimodality disease activity assessment? Rheumatology (Oxford) 61(SI):SI4–SI5. https://doi.org/10.1093/rheumatology/keab644

    Article  PubMed  Google Scholar 

  19. Qiao H, Bai J, Chen Y, Tian J (2007) Kidney modelling for FDG excretion with PET. Int J Biomed Imaging 2007:63234. https://doi.org/10.1155/2007/63234

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ma L, Wu B, Sun Y, Ding Z, Dai X, Wang L, Dai X, Zhang L, Chen H, Ma L, Lv P, Shi H, Jiang L (2023) PET vascular activity score for predicting new angiographic lesions in patients with Takayasu arteritis: a Chinese cohort study. Rheumatology (Oxford) https://doi.org/10.1093/rheumatology/kead056

  21. Ma LY, Wu B, Jin XJ, Sun Y, Kong XF, Ji ZF, Chen RY, Cui XM, Shi HC, Jiang LD (2022) A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study. Rheumatology (Oxford) 61:SI14–SI22. https://doi.org/10.1093/rheumatology/keab487

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Substantial contributions to the Conception or design of the work – MO, DPM, CGK or the acquisition, analysis, or interpretation of data for the work – MO, DPM, KS, UR, NJ, VA, SG Drafting the work – MO, DPM or revising it critically for important intellectual content—CGK, KS, UR, NJ, VA, SG Final approval of the version to be published—MO, DPM, CGK, KS, UR, NJ, VA, SG Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved—MO, DPM, CGK, KS, UR, NJ, VA, SG.

Corresponding author

Correspondence to Durga Prasanna Misra.

Ethics declarations

Ethics approval

Waiver of written informed consent was obtained for retrospective retrieval of data without direct contact with patients from the Institute Ethics Committee, SGPGIMS, Lucknow (2021–165-IP-EXP-40, 16 July 2021).

Disclosures

None.

Additional information

Prior conference presentation

The abstract of the presented work has been accepted for a poster presentation at EULAR 2023 in Milan, Italy.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 20 KB)

Supplementary file2 (WMV 1536 KB)

Supplementary file3 (WMV 8146 KB)

Supplementary file4 (WMV 3130 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ora, M., Misra, D.P., Kavadichanda, C.G. et al. Metabolic inflammatory volume and total inflammatory glycolysis: novel parameters to evaluate PET-CT disease activity in Takayasu arteritis. Clin Rheumatol 42, 1855–1861 (2023). https://doi.org/10.1007/s10067-023-06600-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06600-0

Keywords

Navigation